Anti-BCMA CAR-NK Therapy in Relapsed or Refractory Multiple Myeloma

NCT06242249 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma, Refractory

Interventions

BIOLOGICAL: Anti-BCMA CAR-NK

Sponsor

Shahid Beheshti University of Medical Sciences